Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Berkshire Hathaway Inc. Class B's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $1.09T | |
|---|---|---|
| Revenue (ttm) | 384.7B | |
| Net income (ttm) | 85.8B | |
| EPS (ttm) | $39.8 | |
| Shares out | 2.1B | |
| P/E (trailing) | 13.6x | |
| P/E (forward) | 23.0x | |
| Volume | 2,100,315 | |
| Beta | 0.59 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $191.25B | $207.77B | $254.91B | $249.71B | $247.24B | +6.6% |
| Gross profit | $207.84B | $0 | $0 | $0 | $0 | — |
| Operating income | $199.30B | $-26.15B | $125.17B | $115.58B | $87.53B | -18.6% |
| Net income | $89.94B | $-22.76B | $96.22B | $89.00B | $66.97B | -7.1% |
| EPS (diluted) | $39.68 | $-10.33 | $44.27 | $41.27 | $31.04 | -6.0% |
| EBITDA | $210.02B | $-80.03B | $214.55B | $183.73B | $153.83B | -7.5% |
| R&D | — | — | — | — | — | — |
| SG&A | — | $25.06B | $31.50B | $32.71B | $37.42B | +14.3% |
Recent company headlines from major financial publishers.
Under the Base scenario, assigned a 55.0% probability, intrinsic value is estimated at $325.94, implying an expected return of -36.1% from $509.77. This path assumes normalized underwriting profitability, steady freight and energy volume, and gradual capital reinvestment. Disconfirmation would occur if underwriting margins deteriorate significantly or if interest rate cuts accelerate float yield decline before FY2027.
Under the Bull scenario, carrying a 20.0% probability, intrinsic value reaches Potential value of $383.68, reflecting an expected return of -24.7% compared to $509.77. This outcome requires prolonged commercial insurance rate hardening, accelerated capital deployment of liquidity into higher-yielding operating acquisitions, and resolution of utility liabilities without significant equity impairment.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.7% | $353 | $353 | $353 | $353 | $353 |
| 6.7% | $339 | $339 | $339 | $339 | $339 |
| 7.7% | $326 | $326 | $326 | $326 | $326 |
| 8.7% | $313 | $313 | $313 | $313 | $313 |
| 9.7% | $301 | $301 | $301 | $301 | $301 |
Upcoming earnings date and setup when available.
The rating each month's published research edition carried. A rating compares the price at analysis with the Fair value; it is not a record of whether the call was right.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
